Global Malaria Pipeline Highlights Report 2016-2019: H2 2016 Update - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Malaria Pipeline Highlights - 2016 Update" drug pipelines to their offering.

Malaria Pipeline Highlights - 2016 Update, provides most up-to-date information on key pipeline products in the global Malaria market. It covers emerging therapies for Malaria in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Scope of the Report

Clinical Trial Stages:

The report provides Malaria pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Malaria pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Malaria pipeline products by the company.

Short-term Launch Highlights:

Find out which Malaria pipeline products will be launched in the US and Ex-US till 2019.

Key Topics Covered:

1. Malaria Pipeline by Stages

2. Malaria Pipeline by Drug Class

3. Malaria Pipeline by Company

4. Malaria Phase 3 Clinical Trial Insights

5. Malaria Phase 2 Clinical Trial Insights

6. Malaria Phase 1 Clinical Trial Insights

7. Malaria Preclinical Research Insights

8. Malaria Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/cpvzhd/malaria_pipeline

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs